World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

1228

Sum=1281

Publishing Process of This Article

Item

Count

Browse

Download

132

Sum=173

Jan 21, 2025 (publication date) through May 20, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Cheng CH, Hao WR, Cheng TH. Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease. World J Gastroenterol 2025; 31(3): 98783 [PMID: 39839906 DOI: 10.3748/wjg.v31.i3.98783]
URL:	https://www.wjgnet.com/1007-9327/full/v31/i3/98783.htm

Number	Citing Articles
1	Rong Hu, Dan Liu, Xiaofei Sun, Zhong Yu. New Drugs Approved by European Medicines Agency During 2024. European Journal of Medicinal Chemistry 2025; : 117761 doi: 10.1016/j.ejmech.2025.117761